International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10)-WHO Version for ;2019-covid-expanded
Chapter II
Neoplasms
(C00-D48)
-
Coding-Hint
-
Use additional code (U85),
if desired, to identify resistance, non-responsiveness and
refractive properties of the neoplasm to antineoplastic drugs.
-
Excl.:
-
secondary and unspecified neoplasm of lymph nodes (C77.-)
C81.0
Nodular lymphocyte predominant Hodgkin lymphoma
C81.1
Nodular sclerosis (classical) Hodgkin lymphoma
C81.2
Mixed cellularity (classical) Hodgkin lymphoma
C81.3
Lymphocyte depleted (classical) Hodgkin lymphoma
C81.4
Lymphocyte-rich (classical) Hodgkin lymphoma
-
Excl.:
-
nodular lymphocyte predominant Hodgkin lymphoma (C81.0)
C81.7
Other (classical) Hodgkin lymphoma
-
Incl.:
-
Classic Hodgkin lymphoma, type not specified
C81.9
Hodgkin lymphoma, unspecified
-
Incl.:
-
follicular lymphoma with or without diffuse areas
-
Excl.:
-
mature T/NK-cell lymphoma (C84.-)
C82.0
Follicular lymphoma grade I
C82.1
Follicular lymphoma grade II
C82.2
Follicular lymphoma grade III, unspecified
C82.3
Follicular lymphoma grade IIIa
C82.4
Follicular lymphoma grade IIIb
C82.5
Diffuse follicle centre lymphoma
C82.6
Cutaneous follicle centre lymphoma
C82.7
Other types of follicular lymphoma
C82.9
Follicular lymphoma, unspecified
-
Incl.:
-
Nodular lymphoma NOS
C83
Non-follicular
lymphoma
C83.0
Small cell B-cell lymphoma
-
Incl.:
-
Lymphoplasmacytic lymphoma
-
Nodal marginal zone lymphoma
-
Non-leukaemic variant of B-CLL
-
Splenic marginal zone lymphoma
-
Excl.:
-
Chronic lymphocytic leukaemia (C91.1)
-
Waldenström macroglobulinaemia (C88.0)
-
mature T/NK-cell lymphomas (C84.-)
C83.1
Mantle cell lymphoma
-
Incl.:
-
Centrocytic lymphoma
-
Malignant lymphomatous polyposis
C83.3
Diffuse large B-cell lymphoma
-
Incl.:
-
-
Anaplastic
-
CD30-positive
-
Centroblastic
-
Plasmablastic
-
Immunoblastic
-
Subtype not specified
-
T-cell rich
|
-
diffuse large B-cell lymphoma
|
-
Excl.:
-
mediastinal (thymic) large B-cell lymphoma (C85.2)
-
mature T/NK-cell lymphomas (C84.-)
C83.5
Lymphoblastic (diffuse) lymphoma
-
Incl.:
-
B-cell precursor lymphoma
-
Lymphoblastic B-cell lymphoma
-
Lymphoblastic lymphoma NOS
-
Lymphoblastic T-cell lymphoma
-
T-cell precursor lymphoma
-
Incl.:
-
Atypical Burkitt lymphoma
-
“Burkitt-like” lymphoma
-
Excl.:
-
mature B-cell leukaemia Burkitt-type (C91.8)
C83.8
Other non-follicular lymphoma
-
Incl.:
-
Primary effusion B-cell lymphoma
-
Intravascular large B-cell lymphoma
-
Lymphoid granulomatosis
-
Excl.:
-
mediastinal (thymic) large B-cell lymphoma (C85.2)
-
T-cell rich B-cell lymphoma (C83.3)
C83.9
Non-follicular (diffuse) lymphoma, unspecified
C84
Mature
T/NK-cell lymphomas
C84.4
Peripheral T-cell lymphoma, not elsewhere
classified
-
Incl.:
-
Lennert’s lymphoma
-
Lymphoepithelioid lymphoma
C84.5
Other mature T/NK-cell lymphomas
-
Note:
-
If T-cell lineage or involvement is mentioned in conjunction
with a specific lymphoma, code to the more specific
description.
-
Excl.:
-
angioimmunoblastic T-cell lymphoma (C86.5)
-
blastic NK-cell lymphoma (C86.4)
-
enteropathy-type T-cell lymphoma (C86.2)
-
extranodal NK-cell lymphoma, nasal type (C86.0)
-
hepatosplenic T-cell lymphoma (C86.1)
-
primary cutaneous CD30-positive T-cell proliferations (C86.6)
-
subcutaneous panniculitis-like T-cell lymphoma (C86.3)
-
T-cell leukaemia (C91.-)
C84.6
Anaplastic large cell lymphoma, ALK-positive
-
Incl.:
-
Anaplastic large cell lymphoma, CD30-positive
C84.7
Anaplastic large cell lymphoma, ALK-negative
-
Excl.:
-
primary cutaneous CD30-positive T-cell proliferations (C86.6)
C84.8
Cutaneous T-cell lymphoma, unspecified
C84.9
Mature T/NK-cell lymphoma, unspecified
-
Incl.:
-
NK/T cell lymphoma NOS
-
Excl.:
-
mature T-cell lymphoma, not elsewhere classified (C84.4)
C85
Other
and unspecified types of non-Hodgkin lymphoma
C85.1
B-cell lymphoma, unspecified
-
Note:
-
If B-cell lineage or involvement is mentioned in conjunction
with a specific lymphoma, code to the more specific
description.
C85.2
Mediastinal (thymic) large B-cell lymphoma
C85.7
Other specified types of non-Hodgkin lymphoma
C85.9
Non-Hodgkin lymphoma, unspecified
-
Incl.:
-
Lymphoma NOS
-
Malignant lymphoma NOS
-
Non-Hodgkin lymphoma NOS
C86
Other
specified types of T/NK-cell lymphoma
-
Excl.:
-
anaplastic large cell lymphoma, ALK negative (C84.7)
-
anaplastic large cell lymphoma, ALK positive (C84.6)
C86.0
Extranodal NK/T-cell lymphoma, nasal type
C86.1
Hepatosplenic T-cell lymphoma
-
Incl.:
-
Alpha-beta and gamma-delta types
C86.2
Enteropathy-type (intestinal) T-cell lymphoma
-
Incl.:
-
Enteropathy associated T-cell lymphoma
C86.3
Subcutaneous panniculitis-like T-cell lymphoma
C86.4
Blastic NK-cell lymphoma
C86.5
Angioimmunoblastic T-cell lymphoma
-
Incl.:
-
Angioimmunoblastic lymphadenopathy with dysproteinaemia [AILD]
C86.6
Primary cutaneous CD30-positive T-cell
proliferations
-
Incl.:
-
Lymphomatoid papulosis
-
Primary cutaneous anaplastic large-cell lymphoma
-
Primary cutaneous CD30-positive large T-cell lymphoma
C88
Malignant
immunoproliferative diseases
C88.0
Waldenström macroglobulinaemia
-
Incl.:
-
Lymphoplasmacytic lymphoma with IgM-production
-
Macroglobulinaemia (primary)(idiopathic)
-
Excl.:
-
small cell B-cell lymphoma (C83.0)
C88.2
Other heavy chain disease
-
Incl.:
-
Franklin disease
-
Gamma heavy chain disease
-
Mu (µ) heavy chain disease
C88.3
Immunoproliferative small intestinal disease
-
Incl.:
-
Alpha heavy chain disease
-
Mediterranean lymphoma
C88.4
Extranodal marginal zone B-cell lymphoma of
mucosa-associated lymphoid tissue [MALT-lyphoma]
-
Note:
-
Use additional code (C83.3) if desired,
to specify transition to high malignant (diffuse large cell)
lymphoma
-
Incl.:
-
Lymphoma of skin-associated lymphoid tissue (SALT-lymphoma)
-
Lymphoma of bronchial-associated lymphoid tissue (BALT-lymphoma)
C88.7
Other malignant immunoproliferative diseases
C88.9
Malignant immunoproliferative disease, unspecified
-
Incl.:
-
Immunoproliferative disease NOS
C90
Multiple
myeloma and malignant plasma cell neoplasms
-
Incl.:
-
Kahler disease
-
Medullary plasmacytoma
-
Myelomatosis
-
Plasma cell myeloma
-
Excl.:
-
solitary plasmacytoma (C90.3)
C90.1
Plasma cell leukaemia
-
Incl.:
-
Plasmacytic leukaemia
C90.2
Extramedullary plasmacytoma
C90.3
Solitary plasmacytoma
-
Incl.:
-
Localized malignant plasma cell tumour NOS
-
Plasmacytoma NOS
-
Solitary myeloma
C91.0
Acute lymphoblastic leukaemia [ALL]
-
Note:
-
This code should only be used for T-cell and B-cell precursor
leukeamia
C91.1
Chronic lymphocytic leukaemia of B-cell type
-
Incl.:
-
Lymphoplasmacytic leukaemia
-
Richter syndrome
-
Excl.:
-
lymphoplasmacytic lymphoma (C83.0)
C91.3
Prolymphocytic leukaemia of B-cell type
C91.4
Hairy-cell leukaemia
-
Incl.:
-
Leukaemic reticuloendotheliosis
C91.5
Adult T-cell lymphoma/leukaemia [HTLV-1-associated]
-
Incl.:
-
-
Acute
-
Chronic
-
Lymphomatoid
-
Smouldering
|
|
C91.6
Prolymphocytic leukaemia of T-cell type
C91.7
Other lymphoid leukaemia
-
Incl.:
-
T-cell large granular lymphocytic leukaemia (associated with
rheumatoid arthritis)
C91.8
Mature B-cell leukaemia Burkitt-type
-
Excl.:
-
Burkitt lymphoma with little or no bone marrow infiltration (C83.7)
C91.9
Lymphoid leukaemia, unspecified
C92.0
Acute myeloblastic leukaemia [AML]
-
Incl.:
-
Acute myeloblastic leukaemia, minimal differentiation
-
Acute myeloblastic leukaemia (with maturation)
-
AML1/ETO
-
AML M0
-
AML M1
-
AML M2
-
AML with t(8;21)
-
AML (without a FAB classification) NOS
-
Refractory anaemia with excess blasts in transformation
-
Excl.:
-
acute exacerbation of chronic myeloid leukaemia (C92.1)
C92.1
Chronic myeloid leukaemia [CML], BCR/ABL-positive
-
Incl.:
-
Chronic myelogenous leukaemia:
-
Philadelphia chromosome (Ph1) positive
-
t(9:22)(q34; q11)
-
with crisis of blast cells
-
Excl.:
-
atypical chronic myeloid leukaemia, BCR/ABL-negative (C92.2)
-
chronic myelomonocytic leukaemia (C93.1)
-
unclassified myeloproliferative disease (D47.1)
C92.2
Atypical chronic myeloid leukaemia, BCR/ABL-
negative
-
Note:
-
a tumour of immature myeloid cells
-
Incl.:
-
Chloroma
-
Granulocytic sarcoma
C92.4
Acute promyelocytic leukaemia [PML]
-
Incl.:
-
AML M3
-
AML Me with t(15; 17) and variants
C92.5
Acute myelomonocytic leukaemia
-
Incl.:
-
AML M4
-
AML M4 Eo with inv(16) or t(16;16)
C92.6
Acute myeloid leukaemia with 11q23-abnormality
-
Incl.:
-
Acute myeloid leukaemia with variation of MLL-gene
C92.7
Other myeloid leukaemia
-
Excl.:
-
chronic eosinophilic leukaemia [hypereosinophilic syndrome] (D47.5)
C92.8
Acute myeloid leukaemia with multilineage
dysplasia
-
Note:
-
Acute myeloid leukaemia with dysplasia of remaining
haematopoesis and/or myelodysplastic disease in its history.
C92.9
Myeloid leukaemia, unspecified
-
Incl.:
-
monocytoid leukaemia
C93.0
Acute monoblastic/monocytic leukaemia
-
Incl.:
-
AML M5a
-
AML M5b
-
AML M5
C93.1
Chronic myelomonocytic leukaemia
-
Incl.:
-
Chronic monocytic leukaemia
-
CMML-1
-
CMML-2
-
CMML with eosinophilia
C93.3
Juvenile myelomonocytic leukaemia
C93.7
Other monocytic leukaemia
C93.9
Monocytic leukaemia, unspecified
C94
Other
leukaemias of specified cell type
-
Excl.:
-
leukaemic reticuloendotheliosis (C91.4)
-
plasma cell leukaemia (C90.1)
C94.0
Acute erythroid leukaemia
-
Incl.:
-
Acute myeloid leukaemia M6 (a)(b)
-
Erythroleukaemia
C94.2
Acute megakaryoblastic leukaemia
-
Incl.:
-
Acute myeloid leukaemia, M7
-
Acute megakaryocytic leukaemia
C94.3
Mast cell leukaemia
C94.4
Acute panmyelosis with myelofibrosis
-
Incl.:
-
Acute myelofibrosis
C94.6
Myelodysplastic and myeloproliferative disease,
not elsewhere classified
C94.7
Other specified leukaemias
-
Incl.:
-
Aggressive NK-cell leukaemia
-
Acute basophilic leukaemia
C95
Leukaemia
of unspecified cell type
C95.0
Acute leukaemia of unspecified cell type
-
Incl.:
-
Acute bilineal leukaemia
-
Acute mixed lineage leukaemia
-
Biphenotypic acute leukaemia
-
Stem cell leukaemia of unclear lineage
-
Excl.:
-
acute exacerbation of unspecified chronic leukaemia (C95.1)
C95.1
Chronic leukaemia of unspecified cell type
C95.7
Other leukaemia of unspecified cell type
C95.9
Leukaemia, unspecified
C96
Other
and unspecified malignant neoplasms of lymphoid, haematopoietic
and related tissue
C96.0
Multifocal and multisystemic (disseminated)
Langerhans-cell histiocytosis [Letterer-Siwe disease]
-
Incl.:
-
Histiocytosis X, multisystemic
C96.2
Malignant mast cell tumour
-
Incl.:
-
Aggressive systemic mastocytosis
-
Mast cell sarcoma
-
Excl.:
-
indolent mastocytosis (D47.0)
-
mast cell leukaemia (C94.3)
-
mastocytosis (congenital) (cutaneous) (Q82.2)
C96.4
Sarcoma of dendritic cells (accessory cells)
-
Incl.:
-
Interdigiting dendritic cell sarcoma
-
Langerhans-cell sarcoma
-
Sarcoma of follicular dendritic cells
C96.5
Multifocal and unisystemic Langerhans-cell
histiocytosis
-
Incl.:
-
Hand-Schüller-Christian disease
-
Histiocytosis X, multifocal
C96.6
Unifocal Langerhans-cell histiocytosis
-
Incl.:
-
Eosinophilic granuloma
-
Histiocytosis X, unifocal
-
Histiocytosis X NOS
-
Langerhans-cell histiocytosis NOS
C96.7
Other specified malignant neoplasms of lymphoid,
haematopoietic and related tissue
C96.8
Histiocytic sarcoma
-
Incl.:
-
Malignant Histiocytosis
C96.9
Malignant neoplasm of lymphoid, haematopoietic and
related tissue, unspecified